New Zealand is among the highest scoring in the Policy Context category due to a strong national asthma strategy and severe asthma guidelines, and the country’s reporting to severe asthma registries. New Zealand’s score could be improved by addressing its limited alignment of national care guidelines with international best practices and comparatively modest tobacco control laws. New Zealand’s score in terms of Access and Care Coverage is average. New Zealand has high levels of access to treatment and some diagnostics (inflammatory phenotyping), though limited access to biologics, FeNO-based diagnostics and specialised care.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in New Zealand
Provides further insights into how New Zealand scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
Information about the health impact of severe asthma and severe asthma comorbidities
Factors impacting prevention, management, and exacerbations of severe asthma
Aggregate score across the 5 categories.
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall